Membrane Proteins < Membrane Transport Proteins < Memory

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 26.
[0-20] [0 - 20][0 - 26][20-25][20-40]

Ident.	Authors (with country if any)	Title
000B85 (2011)	Yanwei Xi [Canada] ; Sandra Noble ; Marc Ekker	Modeling neurodegeneration in zebrafish.
001180 (2005)	Wonsuk Yang [États-Unis] ; Evelyn Tiffany-Castiglioni	The bipyridyl herbicide paraquat produces oxidative stress-mediated toxicity in human neuroblastoma SH-SY5Y cells: relevance to the dopaminergic pathogenesis.
001198 (2005)	Wing Lok Au [Canada] ; John R. Adams ; André R. Troiano ; A Jon Stoessl	Parkinson's disease: in vivo assessment of disease progression using positron emission tomography.
001342 (2003)	Raúl De La Fuente-Fernández [Canada] ; Sarah Furtado ; Mark Guttman ; Yoshiaki Furukawa ; Chong S. Lee ; Donald B. Calne ; Thomas J. Ruth ; A Jon Stoessl	VMAT2 binding is elevated in dopa-responsive dystonia: visualizing empty vesicles by PET.
001357 (2003)	Doris J. Doudet [Canada] ; James E. Holden	Raclopride studies of dopamine release: dependence on presynaptic integrity.
001381 (2003)	Frédéric Calon [Canada] ; Ali H. Rajput ; Oleh Hornykiewicz ; Paul J. Bédard ; Thérèse Di Paolo	Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease.
001383 (2003)		Iometopane: (123)I beta-CIT, dopascan injection, GPI 200, RTI 55.
001398 (2003)	A Jon Stoessl [Canada] ; Raúl De La Fuente-Fernández	Dopamine receptors in Parkinson's disease: imaging studies.
001418 (2003)	Raúl De La Fuente-Fernández [Canada] ; Andrew S. Lim ; Vesna Sossi ; Michael J. Adam ; Thomas J. Ruth ; Donald B. Calne ; A Jon Stoessl ; Chong S. Lee	Age and severity of nigrostriatal damage at onset of Parkinson's disease.
001466 (2002)		Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression.
001477 (2002)	Yun J. Kim [Canada] ; Masanori Ichise ; James R. Ballinger ; Douglas Vines ; Sean S. Erami ; Tatsuro Tatschida ; Anthony E. Lang	Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP.
001503 (2001)	C J Sinclair [Canada] ; A E Powell ; W. Xiong ; C G Larivière ; S A Baldwin ; C E Cass ; J D Young ; F E Parkinson	Nucleoside transporter subtype expression: effects on potency of adenosine kinase inhibitors.
001512 (2001)	M. Guttman [Canada] ; D. Stewart ; D. Hussey ; A. Wilson ; S. Houle ; S. Kish	Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD.
001523 (2001)	F. Calon [Canada] ; N. Lavertu ; A M Lemieux ; M. Morissette ; M. Goulet ; R. Grondin ; P J Blanchet ; P J Bédard ; T. Di Paolo	Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter.
001549 (2000)	S. Callier [Canada] ; M. Morissette ; M. Grandbois ; T. Di Paolo	Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice.
001558 (2000)		Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
001578 (2000)	C S Lee [Canada] ; A. Samii ; V. Sossi ; T J Ruth ; M. Schulzer ; J E Holden ; J. Wudel ; P K Pal ; R. De La Fuente-Fernandez ; D B Calne ; A J Stoessl	In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease.
001594 (2000)	J M Van Kampen [Canada] ; E G Mcgeer ; A J Stoessl	Dopamine transporter function assessed by antisense knockdown in the rat: protection from dopamine neurotoxicity.
001620 (1999)	M. Ichise [Canada] ; Y J Kim ; J R Ballinger ; D. Vines ; S S Erami ; F. Tanaka ; A E Lang	SPECT imaging of pre- and postsynaptic dopaminergic alterations in L-dopa-untreated PD.
001645 (1999)	M. Ichise [Canada] ; Y J Kim ; S S Erami ; J R Ballinger ; D. Vines ; F. Tanaka ; A E Lang	Functional morphometry of the striatum in Parkinson's disease on three-dimensional surface display of 123I-beta-CIT SPECT data.
001648 (1999)	D C Vines [Canada] ; B D Ivo ; J R Ballinger ; M. Ichise	External radioactive reference markers in SPECT imaging of the dopamine system.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i -k "Membrane Transport Proteins" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i  \
                -Sk "Membrane Transport Proteins" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Membrane Transport Proteins
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022